Prezzo d'acquisto
25,33
25,33
25,32
233.06 B
Le informazioni sulla prestazione passata non rappresentano un indicatore affidabile della prestazione futura.
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
Creare un account e completare una rapida verifica.
Aggiungi fondi al tuo portafoglio tramite carta, bonifico bancario o crypto.
Scegliete PFE, impostate l'importo e cliccate su compra o vendi: il gioco è fatto!
Pfizer Inc.
PFE
25,325
+0.68%
FAQ